{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T18:14:20Z","timestamp":1773080060605,"version":"3.50.1"},"reference-count":53,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2024,9,18]],"date-time":"2024-09-18T00:00:00Z","timestamp":1726617600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008897","name":"Janssen Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008897","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Ulcerative colitis (UC) is an inflammatory condition characterized by chronic, disabling gastrointestinal symptoms that can have detrimental effects on psychological, social, and professional quality of life. Few studies have examined patient-reported outcomes (PROs) and economic outcomes among individuals with varying UC severity and across different racial\/ethnic groups.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>This cross-sectional study assessed sociodemographic data, PROs, and economic outcomes for participants from the National Health and Wellness Survey (2018, 2019, and 2020) with UC. Multivariable analyses were used to assess the association of self-reported UC severity and race\/ethnicity with health-related quality of life (HRQoL), work productivity and activity impairment (WPAI), healthcare resource utilization (HCRU), and medical costs.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>This study included 1500 participants with UC (1150 non-Hispanic White, 99 non-Hispanic Black, and 251 Hispanic). Moderate\/severe disease was associated with significantly worse HRQoL and WPAI, greater HCRU, and higher direct medical costs than mild UC. Compared with non-Hispanic White participants, non-Hispanic Black participants reported better HRQoL, whereas Hispanic participants reported more HCRU and higher medical costs. Race\/ethnicity significantly interacted with UC severity level in predicting labor force participation.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Participants with moderate\/severe disease had worse outcomes than those with mild UC. Additionally, racial\/ethnic differences were found in HRQoL, employment, WPAI, HCRU, and direct medical costs. Notably, Hispanic participants showed distinct patterns, particularly in how disease severity influenced employment outcomes. Further research is needed to better understand the differential burden among patients across racial\/ethnic groups.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/crocol\/otae048","type":"journal-article","created":{"date-parts":[[2024,9,18]],"date-time":"2024-09-18T05:25:27Z","timestamp":1726637127000},"source":"Crossref","is-referenced-by-count":1,"title":["Patient-Reported Racial and Ethnic Disparities in Patients With Ulcerative Colitis: Results From the National Health and Wellness Survey"],"prefix":"10.1093","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5993-3679","authenticated-orcid":false,"given":"Sabree C","family":"Burbage","sequence":"first","affiliation":[{"name":"Population Health Research, Janssen Scientific Affairs, LLC , Horsham, PA ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathryn L","family":"Krupsky","sequence":"additional","affiliation":[{"name":"Real-World Evidence, Cerner Enviza, an Oracle Company , Kansas City, MO ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M Janelle","family":"Cambron-Mellott","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Morehouse School of Medicine , Atlanta, GA ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nate","family":"Way","sequence":"additional","affiliation":[{"name":"Real-World Evidence, Cerner Enviza, an Oracle Company , Kansas City, MO ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0086-5760","authenticated-orcid":false,"given":"Aarti A","family":"Patel","sequence":"additional","affiliation":[{"name":"Population Health Research, Janssen Scientific Affairs, LLC , Horsham, PA ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia J","family":"Liu","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Morehouse School of Medicine , Atlanta, GA ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2024,9,18]]},"reference":[{"issue":"1","key":"2024101006215820400_CIT0001","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/s41572-020-0205-x","article-title":"Ulcerative colitis","volume":"6","author":"Kobayashi","year":"2020","journal-title":"Nat Rev Dis Primers."},{"issue":"10114","key":"2024101006215820400_CIT0002","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1016\/S0140-6736(17)32448-0","article-title":"Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies","volume":"390","author":"Ng","year":"2017","journal-title":"Lancet."},{"issue":"1","key":"2024101006215820400_CIT0003","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S2468-1253(19)30333-4","article-title":"The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"5","author":"Alatab","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"1","key":"2024101006215820400_CIT0004","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/s41395-018-0233-2","article-title":"Population density and risk of inflammatory bowel disease: a prospective population-based study in 13 countries or regions in Asia-Pacific","volume":"114","author":"Ng","year":"2019","journal-title":"Am J Gastroenterol."},{"issue":"3","key":"2024101006215820400_CIT0005","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1002\/ibd.21058","article-title":"Age distribution of IBD hospitalization","volume":"16","author":"Sonnenberg","year":"2010","journal-title":"Inflamm Bowel Dis."},{"issue":"6","key":"2024101006215820400_CIT0006","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.12740\/PP\/62382","article-title":"Psychiatric illnesses in inflammatory bowel diseases\u2014psychiatric comorbidity and biological underpinnings","volume":"50","author":"Nowakowski","year":"2016","journal-title":"Psychiatr Pol."},{"issue":"8","key":"2024101006215820400_CIT0007","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1093\/ecco-jcc\/jjz024","article-title":"Prevalence and factors associated with fatigue in patients with inflammatory bowel disease: a multicentre study","volume":"13","author":"Chavarr\u00eda","year":"2019","journal-title":"J Crohns Colitis."},{"issue":"7","key":"2024101006215820400_CIT0008","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.dld.2021.03.002","article-title":"Quality of life in patients with moderate to severe ulcerative colitis and the impact of treatment: a narrative review","volume":"53","author":"Armuzzi","year":"2021","journal-title":"Dig Liver Dis."},{"issue":"12","key":"2024101006215820400_CIT0009","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1097\/MIB.0b013e318292fae6","article-title":"The positioning of colectomy in the treatment of ulcerative colitis in the era of biologic therapy","volume":"19","author":"Windsor","year":"2013","journal-title":"Inflamm Bowel Dis."},{"issue":"3","key":"2024101006215820400_CIT0010","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1002\/ibd.22986","article-title":"Systematic review: the role of race and socioeconomic factors on IBD healthcare delivery and effectiveness","volume":"19","author":"Sewell","year":"2013","journal-title":"Inflamm Bowel Dis."},{"issue":"4","key":"2024101006215820400_CIT0011","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.cgh.2019.07.022","article-title":"Lifetime economic burden of Crohn\u2019s disease and ulcerative colitis by age at diagnosis","volume":"18","author":"Lichtenstein","year":"2020","journal-title":"Clin Gastroenterol Hepatol."},{"issue":"4","key":"2024101006215820400_CIT0012","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1080\/03007995.2022.2043655","article-title":"The impact of symptom severity on the humanistic and economic burden of inflammatory bowel disease: a real-world data linkage study","volume":"38","author":"Naegeli","year":"2022","journal-title":"Curr Med Res Opin."},{"issue":"12","key":"2024101006215820400_CIT0013","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1093\/ibd\/izac002","article-title":"Impact of biological therapies and Tofacitinib on real-world work impairment in inflammatory bowel disease patients: a prospective study","volume":"28","author":"Thomas","year":"2022","journal-title":"Inflamm Bowel Dis."},{"issue":"3","key":"2024101006215820400_CIT0014","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1093\/ecco-jcc\/jjv218","article-title":"Self-reported symptom burden in individuals with inflammatory bowel disease","volume":"10","author":"Farrell","year":"2016","journal-title":"J Crohns Colitis."},{"issue":"4","key":"2024101006215820400_CIT0015","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/ibd.20793","article-title":"Impact of ulcerative colitis from patients\u2019 and physicians\u2019 perspectives: results from the UC: NORMAL survey","volume":"15","author":"Rubin","year":"2009","journal-title":"Inflamm Bowel Dis."},{"key":"2024101006215820400_CIT0016","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/1471-230X-12-108","article-title":"Perception gaps between patients with ulcerative colitis and healthcare professionals: an online survey","volume":"12","author":"Schreiber","year":"2012","journal-title":"BMC Gastroenterol."},{"issue":"7","key":"2024101006215820400_CIT0017","first-page":"e41253","article-title":"Race and ethnic categories: a brief review of global terms and nomenclature","volume":"15","author":"Lewis","year":"2023","journal-title":"Cureus"},{"key":"2024101006215820400_CIT0018","doi-asserted-by":"crossref","article-title":"Racial and ethnic disparities in access to health care among adults in the United States: a 20-year national health interview survey analysis, 1999-2018","author":"Caraballo","DOI":"10.1101\/2020.10.30.20223420"},{"key":"2024101006215820400_CIT0019","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1146\/annurev-publhealth-032315-021439","article-title":"Racial and ethnic disparities in the quality of health care","volume":"37","author":"Fiscella","year":"2016","journal-title":"Annu Rev Public Health."},{"issue":"2","key":"2024101006215820400_CIT0020","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1093\/ibd\/izac124","article-title":"The current state of care for Black and Hispanic inflammatory bowel disease patients","volume":"29","author":"Liu","year":"2023","journal-title":"Inflamm Bowel Dis."},{"issue":"12","key":"2024101006215820400_CIT0021","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1016\/j.cgh.2008.07.032","article-title":"Inflammatory bowel disease in African American children compared with other racial\/ethnic groups in a multicenter registry","volume":"6","author":"White","year":"2008","journal-title":"Clin Gastroenterol Hepatol."},{"issue":"7","key":"2024101006215820400_CIT0022","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1007\/s10620-020-06434-9","article-title":"Black race and public insurance are predictive of inappropriate evaluation of iron deficiency anemia and diarrhea","volume":"66","author":"Anyane-Yeboa","year":"2021","journal-title":"Dig Dis Sci."},{"issue":"10","key":"2024101006215820400_CIT0023","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1038\/ajg.2010.202","article-title":"Racial disparities in utilization of specialist care and medications in inflammatory bowel disease","volume":"105","author":"Nguyen","year":"2010","journal-title":"Am J Gastroenterol."},{"issue":"4","key":"2024101006215820400_CIT0024","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.crohns.2013.09.001","article-title":"National estimates of the burden of inflammatory bowel disease among racial and ethnic groups in the United States","volume":"8","author":"Nguyen","year":"2014","journal-title":"J Crohns Colitis."},{"issue":"7","key":"2024101006215820400_CIT0025","doi-asserted-by":"crossref","first-page":"e63","DOI":"10.1097\/MCG.0000000000001204","article-title":"Race\/ethnicity-specific disparities in in-hospital mortality and hospital charges among inflammatory bowel disease-related hospitalizations in the United States","volume":"54","author":"Galoosian","year":"2020","journal-title":"J Clin Gastroenterol."},{"key":"2024101006215820400_CIT0026","author":"Cerner Enviza","year":"2022"},{"issue":"9","key":"2024101006215820400_CIT0027","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1097\/JOM.0b013e318229aae4","article-title":"Direct and indirect costs and potential cost savings of laparoscopic adjustable gastric banding among obese patients with diabetes","volume":"53","author":"Finkelstein","year":"2011","journal-title":"J Occup Environ Med."},{"issue":"S3","key":"2024101006215820400_CIT0028","first-page":"3","article-title":"Prevalence of combinations of diabetes complications across NHANES and NHWS","volume":"25","author":"Strader","year":"2016","journal-title":"Pharmacoepidemiol Drug Saf."},{"issue":"4 Pt 1","key":"2024101006215820400_CIT0029","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1111\/j.1475-6773.2004.00269.x","article-title":"Development of the Patient Activation Measure (PAM): conceptualizing and measuring activation in patients and consumers","volume":"39","author":"Hibbard","year":"2004","journal-title":"Health Serv Res."},{"key":"2024101006215820400_CIT0030","volume-title":"SF-36 Physical and Mental Health Summary Scales. A User\u2019s Manual","author":"Ware","year":"1994"},{"issue":"10","key":"2024101006215820400_CIT0031","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1007\/s11136-011-9903-x","article-title":"Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L)","volume":"20","author":"Herdman","year":"2011","journal-title":"Qual Life Res."},{"issue":"5","key":"2024101006215820400_CIT0032","doi-asserted-by":"crossref","first-page":"353","DOI":"10.2165\/00019053-199304050-00006","article-title":"The validity and reproducibility of a work productivity and activity impairment instrument","volume":"4","author":"Reilly","year":"1993","journal-title":"PharmacoEcon."},{"key":"2024101006215820400_CIT0033","volume-title":"Number of people in thousands, United States, 1996-2018. Medical Expenditure Panel Survey","author":"Agency for Healthcare Research and Quality","year":"2018"},{"key":"2024101006215820400_CIT0034","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/1471-2474-12-83","article-title":"Evaluating the health and economic impact of osteoarthritis pain in the workforce: results from the National Health and Wellness Survey","volume":"12","author":"Dibonaventura","year":"2011","journal-title":"BMC Musculoskelet Disord."},{"key":"2024101006215820400_CIT0035","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1477-7525-10-30","article-title":"Impact of self-rated osteoarthritis severity in an employed population: cross-sectional analysis of data from the national health and wellness survey","volume":"10","author":"Dibonaventura","year":"2012","journal-title":"Health Qual Life Outcomes."},{"issue":"6","key":"2024101006215820400_CIT0036","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1007\/s11136-004-7713-0","article-title":"Comparison of the minimally important difference for two health state utility measures: EQ-5D and SF-6D","volume":"14","author":"Walters","year":"2005","journal-title":"Qual Life Res."},{"key":"2024101006215820400_CIT0037","volume-title":"SF-36 Health Survey Manual and Interpretation Guide","author":"Ware","year":"1992"},{"issue":"3","key":"2024101006215820400_CIT0038","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1017\/S0033291704003514","article-title":"Lifetime risk and persistence of psychiatric disorders across ethnic groups in the United States","volume":"35","author":"Breslau","year":"2005","journal-title":"Psychol Med."},{"issue":"1","key":"2024101006215820400_CIT0039","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1017\/S0033291705006161","article-title":"Specifying race-ethnic differences in risk for psychiatric disorder in a USA national sample","volume":"36","author":"Breslau","year":"2006","journal-title":"Psychol Med."},{"key":"2024101006215820400_CIT0040","doi-asserted-by":"crossref","first-page":"114085","DOI":"10.1016\/j.socscimed.2021.114085","article-title":"Evaluating hypothesized explanations for the Black-White depression paradox: a critical review of the extant evidence","volume":"281","author":"Pamplin","year":"2021","journal-title":"Soc Sci Med."},{"issue":"1","key":"2024101006215820400_CIT0041","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1080\/13607863.2020.1855627","article-title":"Is the Black-White mental health paradox consistent across age, gender, and psychiatric disorders","volume":"26","author":"Thomas Tobin","year":"2022","journal-title":"Aging Ment Health."},{"issue":"2","key":"2024101006215820400_CIT0042","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/jftr.12192","article-title":"Ethnic-racial socialization and the mental health of African Americans: a critical review","volume":"9","author":"Reynolds","year":"2017","journal-title":"J Family Theory Rev"},{"issue":"9","key":"2024101006215820400_CIT0043","doi-asserted-by":"crossref","first-page":"5212","DOI":"10.19082\/5212","article-title":"The correlation of social support with mental health: a meta-analysis","volume":"9","author":"Harandi","year":"2017","journal-title":"Electron Physician"},{"issue":"10","key":"2024101006215820400_CIT0044","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1007\/s00127-019-01707-9","article-title":"Testing a somatization hypothesis to explain the Black-White depression paradox","volume":"54","author":"Barnes","year":"2019","journal-title":"Soc Psychiatry Psychiatr Epidemiol."},{"issue":"3","key":"2024101006215820400_CIT0045","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/NNR.0b013e31827bf533","article-title":"African American men and women\u2019s attitude toward mental illness, perceptions of stigma, and preferred coping behaviors","volume":"62","author":"Ward","year":"2013","journal-title":"Nurs Res."},{"key":"2024101006215820400_CIT0046","article-title":"The impact of social and cultural environment","volume-title":"Genes, Behavior, and the Social Environment: Moving Beyond the Nature\/Nurture Debate","author":"Hernandez","year":"2006"},{"issue":"2","key":"2024101006215820400_CIT0047","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.cgh.2017.05.047","article-title":"Ethnicity influences phenotype and outcomes in inflammatory bowel disease: a systematic review and meta-analysis of population-based studies","volume":"16","author":"Shi","year":"2018","journal-title":"Clin Gastroenterol Hepatol."},{"issue":"1","key":"2024101006215820400_CIT0048","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.cgh.2022.05.008","article-title":"Effectiveness and safety of biologic therapy in Hispanic vs non-Hispanic patients with inflammatory bowel diseases: a CA-IBD Cohort Study","volume":"21","author":"Nguyen","year":"2023","journal-title":"Clin Gastroenterol Hepatol."},{"key":"2024101006215820400_CIT0049","article-title":"Hispanics and Latinos in industries and occupations","volume-title":"The Economics Daily","author":"Bureau of Labor Statistics, U.S. Department of Labor","year":"2015"},{"issue":"2","key":"2024101006215820400_CIT0050","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1080\/00365521.2021.1999495","article-title":"Occupational physical activity differentially affects the risk for developing later-onset Crohn\u2019s disease and ulcerative colitis among middle-aged and older populations","volume":"57","author":"Furuya","year":"2022","journal-title":"Scand J Gastroenterol."},{"issue":"6","key":"2024101006215820400_CIT0051","first-page":"796","article-title":"Time spent per day in strenuous activity and total physical activity are inversely associated with mucosal healing but not with clinical remission in patients with ulcerative colitis","volume":"34","author":"Watanabe","year":"2021","journal-title":"Ann Gastroenterol"},{"key":"2024101006215820400_CIT0052","doi-asserted-by":"crossref","first-page":"goad004","DOI":"10.1093\/gastro\/goad004","article-title":"Intensity-specific considerations for exercise for patients with inflammatory bowel disease","volume":"11","author":"Ordille","year":"2023","journal-title":"Gastroenterol Rep (Oxf)"},{"issue":"6","key":"2024101006215820400_CIT0053","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1038\/s41591-022-01781-8","article-title":"Patient reported outcome assessment must be inclusive and equitable","volume":"28","author":"Calvert","year":"2022","journal-title":"Nat Med."}],"container-title":["Crohn's &amp; Colitis 360"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/crohnscolitis360\/advance-article-pdf\/doi\/10.1093\/crocol\/otae048\/59172129\/otae048.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/crohnscolitis360\/article-pdf\/6\/4\/otae048\/59698351\/otae048.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/crohnscolitis360\/article-pdf\/6\/4\/otae048\/59698351\/otae048.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T11:34:43Z","timestamp":1728560083000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/crohnscolitis360\/article\/doi\/10.1093\/crocol\/otae048\/7759840"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,18]]},"references-count":53,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,10,1]]}},"URL":"https:\/\/doi.org\/10.1093\/crocol\/otae048","relation":{},"ISSN":["2631-827X"],"issn-type":[{"value":"2631-827X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,10]]},"published":{"date-parts":[[2024,9,18]]},"article-number":"otae048"}}